Answers are grounded in this paper and cite their sources.
Preclinical analysis estimates ctDNA shedding duration in cancer, suggesting implications for screening design.
These results provide estimates for average ctDNA detectable sojourn time in tumors across multiple cancer sites and stages and can inform the design of future screening studies for multicancer early detection.
No takes yet. Share an insight, caveat, or question.
Hubbell et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: